QCG
MDCO

Quadrant Capital Group’s Medicines Co MDCO Stock Holding History

Quadrant Capital Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,527
Closed -$128K – 2370
2019
Q4 		$128K Buy
1,527
+62
+4% +$4.13K 0.02% 844
2019
Q3 		$71K Sell
1,465
-14
-0.9% -$558 0.01% 1074
2019
Q2 		$52K Buy
+1,479
New +$48.3K 0.01% 1207
2018
Q4 		– Sell
-57
Closed -$1K – 2367
2018
Q3 		$1K Hold
57
– – ﹤0.01% 2086
2018
Q2 		$2K Hold
57
– – ﹤0.01% 1955
2018
Q1 		$1K Buy
57
+3
+6% +$94 ﹤0.01% 2106
2017
Q4 		$1K Sell
54
-19
-26% -$585 ﹤0.01% 2060
2017
Q3 		$2K Hold
73
– – ﹤0.01% 1886
2017
Q2 		$0 Hold
73
– – ﹤0.01% 2164
2017
Q1 		$2K Hold
73
– – ﹤0.01% 1704
2016
Q4 		$1K Hold
73
– – ﹤0.01% 1890
2016
Q3 		$2K Buy
73
+19
+35% +$716 ﹤0.01% 1555
2016
Q2 		$1K Sell
54
-162
-75% -$5.71K ﹤0.01% 1866
2016
Q1 		$6K Buy
+216
New +$7.05K ﹤0.01% 1131

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Quadrant Capital Group's MDCO Position: Q1 2020 in Review

Quadrant Capital Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,527 shares — an estimated $128K sold.

Quadrant Capital Group first reported a position in MDCO in Q1 2016 and held it in 14 quarters. The position peaked at $128K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Quadrant Capital Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Quadrant Capital Group sold 1,527 Medicines Co shares in Q1 2020, an estimated $128K.
  • Quadrant Capital Group first reported a position in Medicines Co in Q1 2016 and held it in 14 quarters.
  • Quadrant Capital Group's Medicines Co position peaked at $128K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Quadrant Capital Group's 13F filing for Q1 2020, filed 15 May 2020.